{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T10:48:08Z","timestamp":1785322088642,"version":"3.55.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Xiamen Natural Science Foundation of China","award":["3502Z20227347"],"award-info":[{"award-number":["3502Z20227347"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-20167-7","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T14:24:58Z","timestamp":1760711098000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["HSP90\/PUS7\/THUMPD1 promotes metastasis and cisplatin resistance in gastric cancer cells"],"prefix":"10.1038","volume":"15","author":[{"given":"Ziwei","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renjie","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenchun","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhen","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"key":"20167_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"20167_CR2","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","volume":"392","author":"GBD Disease","year":"2018","unstructured":"Disease, G. B. D., Injury, I. & Prevalence, C. Global, regional, and National incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the global burden of disease study 2017. Lancet 392, 1789\u20131858. https:\/\/doi.org\/10.1016\/S0140-6736(18)32279-7 (2018).","journal-title":"Lancet"},{"key":"20167_CR3","doi-asserted-by":"publisher","unstructured":"Machlowska, J., Baj, J., Sitarz, M., Maciejewski, R. & Sitarz, R. Gastric cancer: epidemiology, risk factors, classification, genomic characteristics and treatment strategies. Int. J. Mol. Sci. 21 https:\/\/doi.org\/10.3390\/ijms21114012 (2020).","DOI":"10.3390\/ijms21114012"},{"key":"20167_CR4","doi-asserted-by":"publisher","first-page":"3610","DOI":"10.1038\/s41388-021-01786-6","volume":"40","author":"L Mao","year":"2021","unstructured":"Mao, L. et al. EphA2-YES1-ANXA2 pathway promotes gastric cancer progression and metastasis. Oncogene 40, 3610\u20133623. https:\/\/doi.org\/10.1038\/s41388-021-01786-6 (2021).","journal-title":"Oncogene"},{"key":"20167_CR5","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1080\/02656736.2017.1283065","volume":"33","author":"ZH Ji","year":"2017","unstructured":"Ji, Z. H. et al. Current status and future prospects of clinical trials on CRS\u2009+\u2009HIPEC for gastric cancer peritoneal metastases. Int. J. Hyperth. 33, 562\u2013570. https:\/\/doi.org\/10.1080\/02656736.2017.1283065 (2017).","journal-title":"Int. J. Hyperth."},{"key":"20167_CR6","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1002\/jso.24912","volume":"117","author":"D Mizrak Kaya","year":"2018","unstructured":"Mizrak Kaya, D. et al. Risk of peritoneal metastases in patients who had negative peritoneal staging and received therapy for localized gastric adenocarcinoma. J. Surg. Oncol. 117, 678\u2013684. https:\/\/doi.org\/10.1002\/jso.24912 (2018).","journal-title":"J. Surg. Oncol."},{"key":"20167_CR7","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ctrv.2016.06.007","volume":"48","author":"PH Sugarbaker","year":"2016","unstructured":"Sugarbaker, P. H. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of Gastrointestinal cancers with peritoneal metastases: progress toward a new standard of care. Cancer Treat. Rev. 48, 42\u201349. https:\/\/doi.org\/10.1016\/j.ctrv.2016.06.007 (2016).","journal-title":"Cancer Treat. Rev."},{"key":"20167_CR8","doi-asserted-by":"publisher","first-page":"e770","DOI":"10.1002\/ctm2.770","volume":"12","author":"HY Jiang","year":"2022","unstructured":"Jiang, H. Y. et al. Ubiquitylation of Cyclin C by HACE1 regulates cisplatin-associated sensitivity in gastric cancer. Clin. Transl Med. 12, e770. https:\/\/doi.org\/10.1002\/ctm2.770 (2022).","journal-title":"Clin. Transl Med."},{"key":"20167_CR9","doi-asserted-by":"publisher","first-page":"116310","DOI":"10.1016\/j.biopha.2024.116310","volume":"173","author":"J Liu","year":"2024","unstructured":"Liu, J. et al. Deciphering drug resistance in gastric cancer: potential mechanisms and future perspectives. Biomed. Pharmacother. 173, 116310. https:\/\/doi.org\/10.1016\/j.biopha.2024.116310 (2024).","journal-title":"Biomed. Pharmacother"},{"key":"20167_CR10","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.4103\/njcp.njcp_68_19","volume":"22","author":"HW Lee","year":"2019","unstructured":"Lee, H. W. & Kim, K. M. Clinical significance of heat shock protein 90alpha expression as a biomarker of prognosis in patients with gastric cancer. Niger J. Clin. Pract. 22, 1698\u20131705. https:\/\/doi.org\/10.4103\/njcp.njcp_68_19 (2019).","journal-title":"Niger J. Clin. Pract."},{"key":"20167_CR11","doi-asserted-by":"publisher","first-page":"5890","DOI":"10.7150\/jca.46343","volume":"11","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y. et al. Diagnostic, clinicopathologic, therapeutic and prognostic value of plasma heat shock protein 90 levels in patients with advanced Gastrointestinal carcinoma. J. Cancer. 11, 5890\u20135899. https:\/\/doi.org\/10.7150\/jca.46343 (2020).","journal-title":"J. Cancer"},{"key":"20167_CR12","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12943-020-01208-3","volume":"19","author":"M Xie","year":"2020","unstructured":"Xie, M. et al. Exosomal circSHKBP1 promotes gastric cancer progression via regulating the miR-582-3p\/HUR\/VEGF axis and suppressing HSP90 degradation. Mol. Cancer. 19, 112. https:\/\/doi.org\/10.1186\/s12943-020-01208-3 (2020).","journal-title":"Mol. Cancer"},{"key":"20167_CR13","doi-asserted-by":"publisher","first-page":"217354","DOI":"10.1016\/j.canlet.2024.217354","volume":"610","author":"K Yoshimura","year":"2025","unstructured":"Yoshimura, K. et al. HSP90 inhibitor AUY922 suppresses tumor growth and modulates immune response through YAP1-TEAD pathway Inhibition in gastric cancer. Cancer Lett. 610, 217354. https:\/\/doi.org\/10.1016\/j.canlet.2024.217354 (2025).","journal-title":"Cancer Lett."},{"key":"20167_CR14","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.canlet.2017.05.021","volume":"402","author":"GP Nagaraju","year":"2017","unstructured":"Nagaraju, G. P. et al. Epigenetic effects of Inhibition of heat shock protein 90 (HSP90) in human pancreatic and colon cancer. Cancer Lett. 402, 110\u2013116. https:\/\/doi.org\/10.1016\/j.canlet.2017.05.021 (2017).","journal-title":"Cancer Lett."},{"key":"20167_CR15","doi-asserted-by":"publisher","first-page":"e1811","DOI":"10.1002\/ctm2.1811","volume":"14","author":"Y Chang","year":"2024","unstructured":"Chang, Y. et al. PUS7-dependent pseudouridylation of ALKBH3 mRNA inhibits gastric cancer progression. Clin. Transl Med. 14, e1811. https:\/\/doi.org\/10.1002\/ctm2.1811 (2024).","journal-title":"Clin. Transl Med."},{"key":"20167_CR16","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s13019-023-02332-z","volume":"18","author":"G Zhang","year":"2023","unstructured":"Zhang, G. et al. Higher expression of Pseudouridine synthase 7 promotes non-small cell lung cancer progression and suggests a poor prognosis. J. Cardiothorac. Surg. 18, 222. https:\/\/doi.org\/10.1186\/s13019-023-02332-z (2023).","journal-title":"J. Cardiothorac. Surg."},{"key":"20167_CR17","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/mc.23473","volume":"62","author":"Q Zhang","year":"2023","unstructured":"Zhang, Q. et al. PUS7 promotes the proliferation of colorectal cancer cells by directly stabilizing SIRT1 to activate the Wnt\/beta-catenin pathway. Mol. Carcinog. 62, 160\u2013173. https:\/\/doi.org\/10.1002\/mc.23473 (2023).","journal-title":"Mol. Carcinog."},{"key":"20167_CR18","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/s43018-021-00238-0","volume":"2","author":"Q Cui","year":"2021","unstructured":"Cui, Q. et al. Targeting PUS7 suppresses tRNA pseudouridylation and glioblastoma tumorigenesis. Nat. Cancer. 2, 932\u2013949. https:\/\/doi.org\/10.1038\/s43018-021-00238-0 (2021).","journal-title":"Nat. Cancer"},{"key":"20167_CR19","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s13046-021-01951-5","volume":"40","author":"D Song","year":"2021","unstructured":"Song, D. et al. HSP90-dependent PUS7 overexpression facilitates the metastasis of colorectal cancer cells by regulating LASP1 abundance. J. Exp. Clin. Cancer Res. 40, 170. https:\/\/doi.org\/10.1186\/s13046-021-01951-5 (2021).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"20167_CR20","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1007\/s10620-021-06936-0","volume":"67","author":"J Du","year":"2022","unstructured":"Du, J., Gong, A., Zhao, X. & Wang, G. Pseudouridylate synthase 7 promotes cell proliferation and invasion in colon cancer through activating PI3K\/AKT\/mTOR signaling pathway. Dig. Dis. Sci. 67, 1260\u20131270. https:\/\/doi.org\/10.1007\/s10620-021-06936-0 (2022).","journal-title":"Dig. Dis. Sci."},{"key":"20167_CR21","doi-asserted-by":"publisher","first-page":"115628","DOI":"10.1016\/j.bcp.2023.115628","volume":"213","author":"J Luo","year":"2023","unstructured":"Luo, J., Cao, J., Chen, C. & Xie, H. Emerging role of RNA acetylation modification ac4C in diseases: current advances and future challenges. Biochem. Pharmacol. 213, 115628. https:\/\/doi.org\/10.1016\/j.bcp.2023.115628 (2023).","journal-title":"Biochem. Pharmacol."},{"key":"20167_CR22","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.21037\/jgo-21-641","volume":"12","author":"Q Chen","year":"2021","unstructured":"Chen, Q. et al. MiR-873-5p targets THUMPD1 to inhibit gastric cancer cell behavior and chemoresistance. J. Gastrointest. Oncol. 12, 2061\u20132072. https:\/\/doi.org\/10.21037\/jgo-21-641 (2021).","journal-title":"J. Gastrointest. Oncol."},{"key":"20167_CR23","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/nrc.2017.118","volume":"18","author":"T Brabletz","year":"2018","unstructured":"Brabletz, T., Kalluri, R., Nieto, M. A. & Weinberg, R. A. EMT in cancer. Nat. Rev. Cancer. 18, 128\u2013134. https:\/\/doi.org\/10.1038\/nrc.2017.118 (2018).","journal-title":"Nat. Rev. Cancer"},{"key":"20167_CR24","doi-asserted-by":"publisher","unstructured":"Bernegger, S., Jarzab, M., Wessler, S. & Posselt, G. Proteolytic landscapes in gastric pathology and cancerogenesis. Int. J. Mol. Sci. 23 https:\/\/doi.org\/10.3390\/ijms23052419 (2022).","DOI":"10.3390\/ijms23052419"},{"key":"20167_CR25","doi-asserted-by":"publisher","unstructured":"Sammarco, G. et al. Mast cells, angiogenesis and lymphangiogenesis in human gastric cancer. Int. J. Mol. Sci. 20 https:\/\/doi.org\/10.3390\/ijms20092106 (2019).","DOI":"10.3390\/ijms20092106"},{"key":"20167_CR26","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13045-022-01347-8","volume":"15","author":"Y Huang","year":"2022","unstructured":"Huang, Y., Hong, W. & Wei, X. The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis. J. Hematol. Oncol. 15, 129. https:\/\/doi.org\/10.1186\/s13045-022-01347-8 (2022).","journal-title":"J. Hematol. Oncol."},{"key":"20167_CR27","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","volume":"20","author":"A Dongre","year":"2019","unstructured":"Dongre, A. & Weinberg, R. A. New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer. Nat. Rev. Mol. Cell. Biol. 20, 69\u201384. https:\/\/doi.org\/10.1038\/s41580-018-0080-4 (2019).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"20167_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/15748928113089990031","volume":"9","author":"K Sidera","year":"2014","unstructured":"Sidera, K. & Patsavoudi, E. HSP90 inhibitors: current development and potential in cancer therapy. Recent. Pat. Anticancer Drug Discov. 9, 1\u201320 (2014).","journal-title":"Recent. Pat. Anticancer Drug Discov"},{"key":"20167_CR29","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.2174\/1389450118666170823121248","volume":"19","author":"J Saini","year":"2018","unstructured":"Saini, J., Sharma, P. K. & Clinical Prognostic and therapeutic significance of heat shock proteins in cancer. Curr. Drug Targets. 19, 1478\u20131490. https:\/\/doi.org\/10.2174\/1389450118666170823121248 (2018).","journal-title":"Curr. Drug Targets"},{"key":"20167_CR30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2147\/LCTT.S60344","volume":"7","author":"K Esfahani","year":"2016","unstructured":"Esfahani, K. & Cohen, V. HSP90 as a novel molecular target in non-small-cell lung cancer. Lung Cancer (Auckl). 7, 11\u201317. https:\/\/doi.org\/10.2147\/LCTT.S60344 (2016).","journal-title":"Lung Cancer (Auckl)"},{"key":"20167_CR31","doi-asserted-by":"publisher","first-page":"335","DOI":"10.2174\/1389200219666180307122441","volume":"19","author":"A Akram","year":"2018","unstructured":"Akram, A. et al. Therapeutic uses of HSP90 inhibitors in Non-Small cell lung carcinoma (NSCLC). Curr. Drug Metab. 19, 335\u2013341. https:\/\/doi.org\/10.2174\/1389200219666180307122441 (2018).","journal-title":"Curr. Drug Metab."},{"key":"20167_CR32","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","volume":"740","author":"S Dasari","year":"2014","unstructured":"Dasari, S. & Tchounwou, P. B. Cisplatin in cancer therapy: molecular mechanisms of action. Eur. J. Pharmacol. 740, 364\u2013378. https:\/\/doi.org\/10.1016\/j.ejphar.2014.07.025 (2014).","journal-title":"Eur. J. Pharmacol."},{"key":"20167_CR33","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s00280-023-04572-1","volume":"92","author":"C Liu","year":"2023","unstructured":"Liu, C., Li, S. & Tang, Y. Mechanism of cisplatin resistance in gastric cancer and associated MicroRNAs. Cancer Chemother. Pharmacol. 92, 329\u2013340. https:\/\/doi.org\/10.1007\/s00280-023-04572-1 (2023).","journal-title":"Cancer Chemother. Pharmacol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20167-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20167-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20167-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T14:24:59Z","timestamp":1760711099000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20167-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["20167"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-20167-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"assertion":[{"value":"24 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All animal care and experimental procedures adhered to the guidelines approved by the Animal Ethics Committee of Xiamen University (License Number: XMULAC20240197). All methods were carried out in accordance with relevant guidelines and regulations. All methods are reported in accordance with ARRIVE guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have agreed to publish this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"36331"}}